Zhendong Pharmaceutical Announces Publication of Phase IIb Study of Investigational Vaginal Lactobacillus Capsule in the National Medical Journal of China

Contributed by: PR Newswire

Tags

Zhendong-Pharma

More Like This

PR Newswire associated0

BioFlag Showcases Innovative Probiotic Solutions at Vitafoods Europe 2025

PR Newswire associated0

Zhiyi Biotech Successfully Completes Phase I Clinical Trial of SK10 for the Treatment of Chemotherapy-induced Diarrhea

Meiji Seika Pharma: Results from the Global Phase III Trial (Integral-2) of Nacubactam, a Novel β-Lactamase Inhibitor, Highlighted in The Lancet Microbe’s Coverage of ESCMID Global Congress 2026

PR Newswire associated0

Angel Group's First Industrialized Strain of Probiotics Anchors Strategic Transformation Towards Biotechnology

PR Newswire associated0

Biotic innovation tackles iron deficiency in women - now recognized across three continents

PR Newswire associated0

Angel Yeast Expands into Probiotics R&D and Production, Advances Biotech Transformation

ILiAD Biotechnologies Announces Lancet Microbe Publication of BPZE1 Phase 2b Clinical Results in Human Challenge Model

Meiji Seika Pharma: Positive Results from the Phase III Integral-1 Trial of Nacubactam, a Novel β-Lactamase Inhibitor, in Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis ― Published in The Lancet